Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business
Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business · The Wall Street Journal

In This Article:

Chief Executive Tom Polen said he believes the separation would help differentiate BD in the medical-technology industry, and allow the company to invest more in innovation and margin growth.